Related Experiment Video
Updated: Mar 10, 2026

Simulating Pancreatic Neuroplasticity: In Vitro Dual-neuron Plasticity Assay
Published on: April 14, 2014
Pancreatic Neuroendocrine Tumors
Safia N Salaria1, Chanjuan Shi1
1Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, 1161 21st Avenue South, C-3321 MCN, Nashville, TN 37232-2561, USA.
Pancreatic neuroendocrine neoplasms (PanNETs) are often mistaken for other cancers. While Ki67 is a key prognostic marker, distinguishing PanNETs from other neuroendocrine tumors remains challenging.
Area of Science:
- Oncology
- Pathology
- Endocrinology
Background:
- Pancreatic neuroendocrine neoplasms (PanNETs) encompass well-differentiated tumors and neuroendocrine carcinomas (NECs).
- PanNETs are frequently misdiagnosed, as other pancreatic and metastatic cancers can mimic their appearance.
- Current diagnostic methods lack specific markers to differentiate PanNETs from neuroendocrine tumors originating elsewhere.
Purpose of the Study:
- To highlight the diagnostic challenges in differentiating PanNETs from mimickers.
- To emphasize the prognostic variability of PanNETs and the limitations of current markers.
Main Methods:
- Review of histopathological features of pancreatic neuroendocrine neoplasms.
- Discussion of immunohistochemical staining utility in differential diagnosis.
- Analysis of prognostic factors, including Ki67.
Main Results:
- Well-differentiated PanNETs constitute the majority of pancreatic neuroendocrine neoplasms.
- Immunohistochemistry aids in differential diagnosis but lacks specific markers for PanNETs versus other neuroendocrine tumors.
- Tumor morphology alone is insufficient for predicting behavior; Ki67 is the sole routinely used molecular prognostic marker.
Conclusions:
- Accurate diagnosis of PanNETs requires careful histopathological evaluation and consideration of immunohistochemical findings.
- The prognostic variability of PanNETs necessitates reliable prognostic markers beyond morphology.
- Further research is needed for specific markers to differentiate PanNETs from other neuroendocrine tumors and to predict tumor behavior more accurately.
Related Concept Videos
Cells and Secretions of the Pancreas
Exocrine function is carried out by acinar cells, organized into clusters known as acini. These cells contribute to digestion by releasing substantial quantities of enzyme-rich, alkaline digestive juices.
Concurrently, the dispersed clusters of endocrine cells throughout the...
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are...
Chronic Pancreatitis II: Collaborative Care
Assessment:

